Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Results 41 - 43 of 43 : « Previous 1 2 3

Recs

0
Member Avatar barabo (< 20) Submitted: 5/16/2007 7:45:34 AM : Outperform Start Price: $6.00 CYTX Score: -56.28

may the fat be with you

Report this Post Reply | Reply | Permalink

Recs

0
Member Avatar digndig (34.95) Submitted: 5/3/2007 5:55:34 PM : Underperform Start Price: $5.86 CYTX Score: +55.44

limited proprietary assets

Report this Post Reply | Reply | Permalink

Recs

0
Member Avatar msamet1 (88.32) Submitted: 3/30/2007 11:03:55 AM : Underperform Start Price: $5.80 CYTX Score: +60.50

Unproven therapeutic approach tried by many previous attempts; no real success stories to date

Report this Post Reply | Reply | Permalink
Results 41 - 43 of 43 : « Previous 1 2 3

Featured Broker Partners


Advertisement